Dashboard
Manage Tickers

AQST


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jmp-securities-maintains-market-outperform-on-aquestive-therapeutics-raises-price-target-to-12
JMP Securities Maintains Market Outperform...
10/09/2025 11:35:07

JMP Securities analyst Jason Butler maintains Aquestive Therapeutics (NASDAQ:AQST) with a Market Outperform and raises the p...

aquestive-secures-new-patents-for-needle-free-epinephrine-film-to-treat-severe-allergies
Aquestive Secures New Patents for Needle-F...
10/08/2025 11:01:42

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

crinetics-pharmaceuticals-blackberry-perpetua-resources-and-other-big-stocks-moving-higher-on-friday
Crinetics Pharmaceuticals, BlackBerry, Per...
09/26/2025 14:23:15

U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceutical...

ars-pharma-urges-fda-to-delay-approval-of-aquestives-allergic-reaction-treatment
ARS Pharma Urges FDA To Delay Approval Of ...
09/23/2025 16:01:54

ARS Pharmaceuticals petitioned the FDA to delay approval of Aquestive's epinephrine film, citing safety, dosing, and cardio...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

coreweave-barrick-mining-fedex-and-other-big-stocks-moving-higher-on-friday
CoreWeave, Barrick Mining, FedEx And Other...
09/19/2025 14:31:28

oppenheimer-maintains-outperform-on-aquestive-therapeutics-raises-price-target-to-8
Oppenheimer Maintains Outperform on Aquest...
09/08/2025 12:21:09

Oppenheimer analyst Francois Brisebois maintains Aquestive Therapeutics (NASDAQ:AQST) with a Outperform and raises the price...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 17:05:59

shoe-carnival-american-eagle-ciena-victorias-secret-and-other-big-stocks-moving-higher-on-thursday
Shoe Carnival, American Eagle, Ciena, Vict...
09/04/2025 16:56:56

fda-confirms-direct-review-path-for-aquestives-allergy-treatment
FDA Confirms Direct Review Path For Aquest...
09/04/2025 16:44:41

Aquestive's Anaphylm could become the first oral epinephrine for severe allergic reactions after the FDA set a 2026 decisio...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

fda-skips-advisory-committee-meeting-for-aquestive-therapeutics-anaphylm-pdufa-date-set-for-january-31-2026
FDA Skips Advisory Committee Meeting For A...
09/04/2025 11:04:11

NDA remains on track for FDA PDUFA goal date of January 31, 2026Commercial planning continues enabling rapid launch following a...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
08/14/2025 17:35:27

aquestive-prices-85-million-stock-offering-of-2125m-shares-at-4share-to-fund-anaphylm-allergy-drug-launch
Aquestive Prices $85 Million Stock Offerin...
08/14/2025 10:30:40

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

aquestive-secures-75m-funding-tied-to-fda-approval-of-oral-allergy-rescue-drug-anaphylm
Aquestive Secures $75M Funding Tied to FDA...
08/14/2025 10:05:57

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

aquestive-therapeutics-affirms-fy2025-sales-guidance-of-44000m-50000m-vs-45059m-est
Aquestive Therapeutics Affirms FY2025 Sale...
08/11/2025 20:02:39

Aquestive Therapeutics (NASDAQ:AQST) affirms FY2025 sales outlook from $44.000 million-$50.000 million to $44.000 million-$50.0...

aquestive-therapeutics-q2-eps-014-beats-017-estimate-sales-10003m-miss-11320m-estimate
Aquestive Therapeutics Q2 EPS $(0.14) Beat...
08/11/2025 20:02:17

Aquestive Therapeutics (NASDAQ:AQST) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

uncovering-potential-aquestive-therapeuticss-earnings-preview
Uncovering Potential: Aquestive Therapeuti...
08/08/2025 16:03:22

aquestive-seeks-approval-for-needle-free-allergy-film-in-canada-and-europe-eyes-global-expansion
Aquestive Seeks Approval for Needle-Free A...
07/15/2025 11:05:12

Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing m...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION